SCHEMBL10018853

SCHEMBL10018853

c1ccc2c(c1)Cc1cc(-c3cccc4c3sc3c(-c5ccc6c(c5)Cc5ccccc5-6)cccc34)ccc1-2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ SRD5A2 P31213 1/20 0.41
▸ CNR1 P21554 1/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ SLC6A2 P23975 2/20 0.39
▸ SLC6A4 P31645 2/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HTR2C P28335 2/20 0.38
▸ HTR2B P41595 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17057183 0.87 ALOX5 (0.42) ALOX5MAPTNPC1RAB9AALDH1A1
SCHEMBL21532712 0.81 ALOX5 (0.54) ALOX5MAPTNPC1RAB9AALDH1A1
SCHEMBL17211241 0.80 MAPT (0.37) ALOX5MAPTNPC1RAB9AALDH1A1
SCHEMBL27950640 0.80 MAPT (0.49) MAPTNPC1RAB9AALDH1A1KDM4E
SCHEMBL19491746 0.80 MAPT (0.36) ALOX5MAPTNPC1RAB9AALDH1A1
SCHEMBL30395577 0.78 ALDH1A1 (0.63) MAPTNPC1RAB9AALDH1A1KDM4E
SCHEMBL3414807 0.78 ALDH1A1 (0.63) MAPTNPC1RAB9AALDH1A1KDM4E
SCHEMBL15613814 0.78 ALOX5 (0.62) ALOX5MAPTRAB9AALDH1A1HPGD
SCHEMBL20248372 0.78 ALOX5 (0.48) ALOX5MAPTNPC1RAB9AALDH1A1
SCHEMBL19543755 0.77 ALOX5 (0.39) ALOX5MAPTNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8743031-B2 Dibenzothiophene compound and organic light-emitting element based on the same CANON KABUSHIKI KAISHA (JP) 2014-06-03 — — US disclosed
US-8743031-B2 Dibenzothiophene compound and organic light-emitting element based on the same CANON KABUSHIKI KAISHA (JP) 2014-06-03 — — US disclosed
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 — — US disclosed
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME TPT1, RFT1, ARNT ALOX5 2608/4885MAPT 1249/4885NPC1 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback